Harvard Bioscience's (HBIO) CEO Jeffrey Duchemin on Q4 2016 Results - Earnings Call Transcript

3/10/17

Harvard Bioscience, Inc. (NASDAQ:HBIO)

Q4 2016 Results Earnings Conference Call

March 9, 2017 4:30 p.m. ET

Executives

Corey Manchester - Director, Finance and Investor Relations

Jeffrey Duchemin - President and Chief Executive Officer

Robert Gagnon - Chief Financial Officer

Analysts

Raymond Myers - The Benchmark Company

Operator

Welcome to the Q4 2016 Harvard Bioscience Inc. Earnings Conference Call. My name is Ally and I will be your operator for today’s call. At this time all participants are in a listen only mode. Later, we will conduct a question-and-answer session. Please note that this conference is being recorded. I will now turn the call over to Corey Manchester, Director of Finance and Investor Relations. Corey, you may begin.

READ FULL ARTICLE HERE